Misdiagnosis of enteric fever is a major global health problem resulting in patient mismanagement, 29 antimicrobial misuse and inaccurate disease burden estimates. Applying a machine-learning algorithm 30 to host gene expression profiles, we identified a diagnostic signature which could accurately 31 distinguish culture-confirmed enteric fever cases from other febrile illnesses (AUROC>95%). 32
Results

71
Transcriptional profiles in response to enteric fever are similar in challenge study and endemic 72 cohorts 73
We recently described the molecular response profile of acute enteric fever in individuals 74 participating in the typhoid CHIM, which was characterized by innate immunity, inflammatory and 75 interferon signalling patterns. 13 
76
To compare responses to enteric fever occurring during natural infection in an endemic area, we 77 generated transcriptional profiles in samples collected from culture-confirmed enteric fever patients 78 (S. Typhi: '03NP-ST'; S. Paratyphi: '03NP-SPT'), healthy community controls ('03NP-CTRL') and 79 febrile, culture-negative suspected enteric fever cases ('03NP-sEF') recruited in Nepal (Kathmandu; 80 Study: '03NP') ( Figure 1a) . We detected significant differential expression (DE; FDR<0.05, 81 FC±1.25) of 4,308 and 4,501 genes in enteric fever patients with confirmed S. Typhi (n=19) and S. 82
Paratyphi (n=12) bacteraemia, respectively, when compared with healthy community controls (n=47; 83
Figure 1b)
. Similar numbers of genes were differentially expressed in samples collected at the time of 84 enteric fever diagnosis in healthy adult volunteers challenged with either S. Typhi ('T1-ST') or S. 85
Paratyphi ('P1-SPT') in a CHIM (Figure 1b ).
7,13
86
As comparison of host responses at the gene level can be difficult to interpret, we performed Gene Set 87 Enrichment Analysis (GSEA) 14 of blood transcriptional modules (BTMs) as a conceptual framework 88 to interpret the host responses in the context of biological pathways and themes. 15 Overall, between 54 89 and 74 BTMs were significantly enriched (BH adjusted p<0.01) in blood culture-confirmed enteric 90 fever cases in the CHIM and natural infection and CHIM participants who did not develop enteric 91 fever (measured at day 7 post-challenge -'nD7) (Supplementary Table 1 ). The majority of BTMs 92 enriched in cases from the enteric fever CHIM were also enriched in naturally infected cases from 93 Nepal (56%-69, Supplementary Table 1-red squares). Positively enriched modules represented cell 94 cycle (CCY), type I/II interferon and innate antiviral responses (IFN), dendritic cell (DC), innate 95 immunity, inflammation and monocyte (Infl./Mono) signatures. In contrast, T cell (TC) signatures 96 were down-regulated in patients with confirmed enteric fever, as we have previously described 97 (Figure 1c-e) . 13 In addition a number of modules including inflammasome receptors (M53), 98 monocyte enrichment (M118.0, M118.1, M81, M4.15, M23, M73, M64, S4) and inflammatory 99 responses (M33) were significantly enriched in the CHIM but not in cases from Nepal. Single sample 100 GSEA (ssGSEA) demonstrated the similar enrichment pattern for a selection of IFN and DC 101 signatures between individuals with confirmed typhoid and paratyphoid fever in the CHIM and 102 naturally infected cases (Figure 1f) . Overall, we observed marked similarity in the gene transcription 103 responses between acute enteric fever cases from the CHIM and an endemic setting in Nepal. 104
105
Responses of febrile, culture-negative samples in Nepal 107
In culture-negative, suspected enteric fever patients ('sEF') from Nepal, we detected differential 108 expression of 3,517 genes when compared with healthy community controls (Supplementary Figure  109 1b). While we observed 2,843 genes as commonly expressed in all three Nepali patient cohorts 110 (03NP-ST, 03NP-SPT and 03NP-sEF), an additional 582, 756 and 183 genes were uniquely expressed 111 by subjects with confirmed S. Typhi, S. Paratyphi or suspected enteric fever, respectively 112 (Supplementary Figure 1a&b) . Unsupervised hierarchical clustering of these patients based on their 113 expression of the 500 most variable genes in the Nepal cohort demonstrated clustering into three 114 groups (Figure 1g ): Group 1 contained mostly healthy control participants; Group 2 contained mostly 115 patients with suspected enteric fever; and Group 3 contained a mixture of patients with suspected 116 enteric fever, and blood culture-confirmed S. Typhi or S. Paratyphi infection. 117
Using ssGSEA we observed a heterogeneous BTM enrichment pattern with broad variability in 118 BTMs representing TC activation patterns, protein folding and metabolism (brown cluster), or in 124 innate response and monocyte signatures (purple cluster) (Supplementary Figure 1c) . These febrile 125 patients were considered clinically to have enteric fever, and were therefore treated as such, however 126 their heterogeneous gene transcription profiles suggest that any one of several different aetiologies 127 may have precipitated hospital presentation. Further evidence to this is that in a recent RCT a higher 128 proportion of culture-negative cases responded to fluoroquinolones rather than a 3 rd generation 129 cephalosporin, possibly due to the frequency of murine and scrub typhus in this population, however 130 distinguishing between these infections is currently difficult. 131 132
Multi-cohort data quality assessment 133
In order to address the potential over-diagnosis of enteric fever and associated inappropriate 134 antimicrobial use, we next aimed to identify a set of genes whose expression is able to differentiate 135 enteric fever from other common febrile conditions found in tropical settings. We repurposed 136 publically available datasets describing host transcriptional response in two malaria, 10, 16 four 137 tuberculosis, 8, 17 and four dengue cohorts (Supplementary Table 2) . 9, 18, 19 We designed a discovery 138 cohort consisting of control samples from each respective study (n=220 community controls or 139 convalescent samples, 'CTRL'), 74 enteric fever ('EF'), 94 blood stage P. falciparum ('bsPf'), 67 140 dengue ('DENV') and 54 active pulmonary tuberculosis ('PTB') cases. An independent validation 141 cohort consisted of 109 CTRLs, 50 EF, 19 bsPf, 49 DENV, and 97 PTB samples (Figure 2) . Finally,a cohort of 'unknown' samples was created consisting of febrile culture-negative, febrile suspected 143 EF cases from Nepal ('sEF'), and samples collected from CHIM study participants who did not elop 144 enteric fever after challenge at day 7 ('nD7') and their respective pre-challenge baseline samples 145 ('D0') (Figure 2) . Using Principle Component Analysis (PCA) to assess the variability at the level of 146 gene expression between the cohorts indicated some distinct clustering between cases 147 (Supplementary Figure 2a) , for each infection whereas no such differences were observed with the 148 comparator CTRL samples (Supplementary Figure 2b) . 149
150
Five genes sufficiently distinguish EF from other febrile infections 151
With these data, we aimed to build a classifier containing a minimum set of genes that could 152 discriminate culture-confirmed enteric fever cases from individuals with other causes of fever (class: 153 'Rest', consisting of CTRLs, DENV, PTB and bsPf) (2-class classification, Figure 2 ) using a Guided 154
Regularized Random Forest (GRRF) algorithm. 20 Genes were ranked by frequency of selection in 155 each of 100 iterations, and applying a selection threshold of ≥25%, we identified a putative diagnostic 156 signature containing STAT1 (98% of iterations), SLAMF8 (76%), PSME2 (39%), WARS (37%), and 157 ALDH1A1 (36%) (Figure 3a) . With this 5-gene signature we were able to predict which individuals 158 in the validation cohort had enteric fever with a sensitivity and specificity of 97.1% and 88.0%, 159 respectively (AUROC: 96.7%) (Figure 3b, Supplementary Table 3a) . Of blood culture-confirmed 160 enteric fever cases in the validation cohort, 6/51 were misclassified as 'Rest' (i.e. classification 161 probability>0.5, Figure 3c -top), and 8/274 samples belonging to class 'Rest' were classified as 162 enteric fever. These included six tuberculosis and one dengue case, and a pre-challenge baseline 163 sample from a CHIM participant (Figure 3c-bottom) . 164
To allow comparison between the different disease conditions, we quantified expression of the 5 165 genes identified in each sample using the z-score of the geometric mean of the expression values 166 (expression score). Significant differences in expression scores were observed between the enteric 167 fever samples and all other conditions in both the discovery (top) and the validation (bottom) cohort 168 (Figure 3d ). Of note, there were no significant differences between the scores calculated for the 169 control samples derived from endemic areas or naïve, healthy controls from the CHIM, indicating the 170 homogeneity of expression to these genes in healthy controls from different study and geographical 171
locations. 172
The design of discovery and validation cohorts is likely to have an impact on the diagnostic signature 173 selected, and we therefore exchanged the validation and discovery cohort and re-ran the analysis. 174
Although in this experiment 4 instead of 5 genes were selected (using a threshold ≥25%), most genes 175 included were also part of the initial signature (STAT1, SLAMF8, WARS) and the high predictive 176 accuracy was maintained (AUROC: 97.2%) (Supplementary Figure 3a&b) . These results 177 demonstrate the ability of a small number of genes to accurately predict true EF cases from other 178 febrile illnesses caused by another bacterial pathogen (TB), and of parasitic or viral origin. 179
180
Multiclass prediction accurately classifies three of five conditions simultaneously 181
Given the apparent success of small gene expression signatures in classifying two distinct groups, we 182 sought to leverage the overall dataset and the GRRF algorithm to identify a signature that could 183 accurately classify more than two classes simultaneously. We re-analysed the data preserving the 184 original class labels (i.e. CTRL, bsPf, DENV, PTB and EF) and performed the iterative feature 185 selection step using the GRRF algorithm (Figure 2-"multiclass classification" ). Applying a ≥25% 186 selection threshold to ranked features identified 7 genes (RFX7, C1QB, ANKRD22, WARS, BATF2, 187 STAT1, and C1QC) able to discriminate the classes (Figure 3e) . Prediction of the validation cohort 188 using this 7-gene signature indicated good sensitivity and specificity for accurately classifying CTRL, 189 bsPf and EF cases, however the identification of DENV and PTB was less accurate (Figure 3f , 190 
Supplementary
Figure 4a&b). 195 196
Prediction of unknown samples 197
Given the superior performance of the 2-class diagnostic signature, our subsequent analyses focused 198 on using the initial 5-genes identified to ascertain whether enteric fever was the likely true underlying 199 aetiology of suspected febrile, blood culture-negative cases in Nepal (sEF; n=71), part of the unknown 200 cohort (Figure 2) . Included in this cohort were 144 samples originating from the challenge study with 201 known class membership confirming the correct classification of 94.4% of the samples by the GRRF 202 algorithm (Supplementary Table 4) . 203
Classification of these sEF cases predicted 9/71 (12.6%) febrile, culture-negative patients to be true 204 enteric fever cases and the remaining samples to belong to class 'Rest' (Figure 4a) . Relating the gene 205 expression scores to the predicted class probabilities indicated no clear separation of scores according 206 to the predicted class (Figure 4b) . Furthermore, comparing the expression score of febrile, culture-207 negative samples with culture confirmed enteric fever in Nepal showed a marked overlap, indicating 208 that these scores alone are insufficient for 2-class discrimination (Figure 4c) . 209
210
Diagnostic validation by qPCR 211
Finally, to validate the induction of the diagnostic gene signature in blood culture-confirmed enteric 212 fever cases, we performed high-throughput qPCR in samples collected during an independent typhoid 213 Table 2) 21 and in the Nepali cohort. Transcription of the 5-gene signature 214 was increased at the time of diagnosis in most participants with culture-confirmed enteric fever in 215 both sample sets (Figure 4d&e) . Two CHIM participants diagnosed with typhoid infection and one 216 patient infected with S. Paratyphi in Nepal showed low expression of all genes and a resulting low 217 expression score (Figure 4e-black arrows) . In contrast, one day 7 sample from a participant not 218 diagnosed with enteric fever demonstrated high expression of the putative diagnostic gene signature 219 (Figure 4e-black arrows) . 220
CHIM (Supplementary
As surrogate disease severity markers, temperature showed poor correlation with the expression score 221 in both CHIM and endemic setting culture-confirmed enteric fever cases (Figure 4f&g-left) . In 222 contrast, C-reactive protein levels (only available for CHIM participants) were significantly 223 associated with the expression score of the 5-gene signature (Figure 4f&g New approaches to diagnose patients with enteric fever are urgently needed, as currently available 232 methods are antiquated and unreliable. New diagnostic modalities are required, to both improve the 233 immediate management of patients, and to increase the accuracy of disease burden measurements to 234 support targeted vaccine implementation. Here we demonstrate a reproducible host expression 235 signature of 5 genes (STAT1, SLAMF8, PSME2, WARS, and ALDH1A1) able to discriminate EF cases 236 from other common causes of fever in the tropics with an accuracy of >96%. To our knowledge, this 237 exceeds the performance of all previously described enteric fever diagnostic methods, which often 238 perform less well when assessed using samples collected directly from patients or participants. 239
Moreover, application of high-throughput methods such as functional genomics, to this major health 240 concern, 22 underscores the importance and tangible benefits of applying 'omics-technologies' to 241 combatting infectious diseases in the most needy populations.
23 While further optimisation work is 242 required, validating the expression of our signature using conventional methods such as qPCR 243 demonstrates feasibility of further development into an affordable diagnostic test for use in endemic 244 settings.
24
245
The degree of perturbation of molecular responses occurring during enteric fever can be confounded 246 by the duration of clinical illness (ranging in 12hrs to ≥3 days in the CHIM and patients from Nepal. overlapping between the two groups, which is unsurprising given the close genetic relatedness of both 251 pathogens.
25 Enrichment of BTMs resembled responses described previously by us 13, 26 and underlined 252 the concordance between culture-confirmed enteric fever cases from Oxford and Nepal despite the 253 possible differences between challenge and currently circulating strains. 254
Despite the multiple redundancies incorporated into human immune pathways driven by successful 255 evolution, 27 our data suggest that the pattern of immune response activation is sufficiently specific to 256 allow identification of the causative pathogen. For example, while immune responses during enteric 257 fever and TB are broadly characterized by IFN-signalling, we and others have reported that this 258 response during acute S. Typhi infection appears to be skewed towards a type-II pattern likely 259 associated with neutrophils and NK cells rather than the type-I dominated profile found in TB. 7,8,13,28- 
260
31 Application of computational methods to large datasets including host gene expression has been 261 shown to be an effective approach to capture such differential activation of immune pathways. 5, 6 Two 262 of the genes identified in our 5-gene diagnostic signature are important entities in the IFN-signalling 263 cascade (STAT1, WARS), which has been broadly implicated in the responses to enteric fever, TB, C1QC are well-known subunits of the complement subcomponent C1q and, together with ANKRD22 282 (involved in cell cycle control 48 ), have previously been described as part of a signature able to 283 distinguish active from latent TB. 17 The function of the transcription factor RFX7 is largely unknown, 284 but has been found to be strongly up-regulated during blood stage malaria and its selection in our 7-285 gene signature is therefore likely to be driving the classification of malaria cases. 286
Of note, while multiclass classification is difficult to perform and here merely serves as demonstration 287 that data driven approaches may be capable of performing this task, it is interesting to observe 288 increased misclassification rates specifically in the DENV and TB groups. In the validation cohort, 289 the majority of misclassified DENV cases were identified as enteric fever (5/49) or TB (9/49), and 290 misclassified TB samples as enteric fever (13/97) or DENV (23/97), possibly reflecting the 291 overlapping immune response seen due to the intracellular nature of all three pathogens. In the TB 292 group, 15/97 samples were misclassified as controls, compared with one DENV sample being 293 misclassified as such for example, potentially owing to the broad clinical phenotype or lack of 294 inflammatory/immune responses seen in the peripheral blood during tissue specific pulmonary TB 295
infection. 296
Overall, the genes identified in both signatures through our unbiased selection approach are supported 297 by previous studies including those aiming to develop predictive diagnostic signatures. 8, 17, 49 In the era 298 of biological 'big data', several studies have explored the utility of gene transcription signatures 299 capable of discriminating viral aetiologies, viral or bacterial infections as well as acute or latent 300 tuberculosis. 5, 6, 17, [50] [51] [52] [53] Only in the tuberculosis studies have such signatures been identified from 301 samples collected in high-incidence, disease endemic settings and been further validated against otherdisease processes including (but not limited to) pneumonia, sepsis, and streptococcal and 303 staphylococcal infections. 6, 8, 50 Herberg et al. demonstrated that distinction between viral and bacterial 304 infections could be achieved based on two genes only. 5 In contrast most efforts undertaken to 305 diagnose active TB employ biomarker signatures ranging in size from 3-86 genes, possibly due to 306 broad and heterologous molecular responses seen in response to differing clinical phenotypes of 307 infection. In our analysis we specifically focused on pathogens with the potential to cause 308 undifferentiated febrile illnesses in tropical settings. While the clinical presentation and epidemiology 309 of the infections chosen may be sufficient to distinguish the aetiologies clinically, enteric fever has a 310 broad differential diagnosis and is frequently over-diagnosed in the absence of confirmatory 311 laboratory results. Notably, despite the high prediction accuracy of the signatures identified in our 312
analysis, this type of data modelling is highly dependent on the quality and availability of suitable 313 input datasets. Although an increasing amount of data is accumulating in the public domain, few well-314 defined datasets of samples representing a larger repertoire of febrile illnesses are available. For 315 example, rickettsial infection is likely to underlie a large burden of the culture-negative cases in 316
Nepal, however no gene expression datasets exist and the lack of adequate confirmatory diagnostic 317 tests further hinders the inclusion of such data in our analysis. 318
Although the 5-gene signature achieved high accuracy in identifying enteric fever cases, several 319 culture-confirmed cases were misclassified. Metadata from samples collected in the Oxford CHIM 320 indicate that the majority of these misclassified samples had a temperature below 37 ○ C (5/6) and were 321 diagnosed beyond 7 days after challenge (4/6), which, in our CHIM experience, is likely to indicate a 322 less severe disease phenotype. In contrast, six nD7 samples from the Oxford CHIM (part of the 323 unknown cohort) classified as enteric fever showed some sign of response either based on increased 324 cytokines, temperature or a positive stool culture (data not shown). Because our analysis was purely 325 data driven and not motivated by clinical suspicion, we believe that these observations and the 326 significant association of the gene expression scores with CRP provide sufficient evidence that these 327 study participants had infection despite not meeting our study endpoint definitions for enteric fever. 328
In summary, our work demonstrates how a large gene expression dataset derived from challenge study 329 cohorts and settings endemic for febrile infectious diseases can be exploited for diagnostic biomarker 330 discovery. Verification of the putative diagnostic signature using qPCR in independent validation sets 331
indicates that a diagnostic test derived from these gene expression data could be developed for 332 deployment in resource-limited settings. The application of purely data-driven analyses to large and 333 well-defined host-pathogen datasets derived from disease relevant populations may enable us to 334 develop a single, highly accurate diagnostic signature which would allow rapid identification of the 335 main fever-causing aetiologies from readily available biological specimens. 336
Online Methods 337
Typhoid challenge model 338
Samples included in the discovery cohort were collected during a typhoid dose-escalation study in 339 which 41 healthy adult volunteers ingested a single dose of S. Typhi Quailes strain following pre-340 treatment with 120 mL sodium bicarbonate solution (Study: T1). In this study, one of two doses were 341 administered: 1-5x10 3 (n=21) and 1-5x10 4 (n=20). 4 Samples used in the validation cohort were 342 collected from a second typhoid challenge model performed as part of a vaccine efficacy study 343 (Study: T2), in which healthy adult volunteers ingested a single dose of S. Typhi Quailes strain (1-344 5x10 4 , n=99) 4 weeks after oral vaccination with Ty21a, M01ZH09 or placebo. 54 Lastly, samples 345 collected from the control arm of a further vaccine efficacy challenge study, in which participants 346 received meningococcal ACWY-CRM conjugate vaccine (MENVEO ® , GlaxoSmithKline) prior to 347 challenge, were used for the independent qPCR validation experiment. 21 The clinical and molecular 348 results of these studies have been described previously. 4, 7, 21, 54 In all typhoid challenge studies 349 participants were treated with a 2-week course of antibiotics at the time of diagnosis (fever ≥38°C 350 sustained for ≥12hrs and/or positive blood culture), or at day 14 post-challenge if diagnostic criteria 351
were not reached. 352
353
Paratyphoid challenge model 354
Clinical samples for paratyphoid infection were collected during a dose-escalation study, as 355 previously described (P1 3 -2.8×10 3 ). Criterion for diagnosis were either microbiological (≥1 positive blood culture 361 collected after day 3) and/or clinical (fever ≥38°C sustained for ≥12hrs). Participants were ambulatory 362 and followed up as outpatients at least daily after challenge when safety, clinical, and laboratory 363 measurements were performed. 
Endemic Cohort 366
To validate the gene transcriptional signatures in a relevant patient cohort, blood samples were 367 collected from three cohorts at Patan Hospital or the Civil Hospital both located in the Lalitpur Sub-368
Metropolitan City area of Kathmandu Valley in Nepal. Firstly, blood samples were collected as part 369 of a diagnostics study 55 from febrile patients presenting to hospital and diagnosed with blood culture-370 confirmed S. Typhi (n=19) or S. Paratyphi A (n=12) infection and febrile patients who were blood 371 culture negative (n=71). Samples from a cohort of healthy control volunteers (n=44) were also 372 collected as part of this study. 373
374
Gene expression arrays sample processing 375
In the human challenge studies (T1, T2, and P1), peripheral venous blood (3mL) was collected in 376
Tempus
TM Blood RNA tubes (Applied Biosystems) before challenge (baseline, pre-challenge controls, 377 'D0', n=166) and at paratyphoid diagnosis ('SPT', n=18) or typhoid diagnosis ('ST', n=75). In those 378 challenged but who did not develop enteric fever within 14 days of challenge, gene expression was 379 measured at the median day of diagnosis of the diagnosed group in the appropriate studies and this 380 day was termed 'nD7' (n=73). In Nepal, blood was collected when patients presented to hospital 381 (n=102) and from healthy controls (n=44) (Figure 1A, Supplementary Table S1 ). Total RNA was 382 extracted from all samples using the Tempus TM Spin RNA Isolation kit (Life Technologies). Where 383 applicable, 50ng of RNA was used for hybridization into Illumina HT-12v4 bead-arrays (Illumina 384 Paired-end reads were adapter removed and trimmed from 75 to 65bp using trimmomatic v0.35 56 and 392 only reads exceeding a mean base quality 5 within all sliding windows of 5bp were mapped to the 393 Gencode v25/hg38 transcriptome using STAR aligner v2.5.2b keeping only multi mapped reads 394 mapping to at most 20 locations. featureCounts from the subread set of tools v1.5.1 was used to 395 quantify reads in Gencode v25 basic gene locations with parameters -C -B -M -s 2 -p -S fr. Between-396 sample normalization was performed using TMM (Trimmed Mean of M-values) normalization as 397 implemented in the edgeR 57 package and we used principle component analysis (PCA) as quality 398 control step and excluded 2 samples, which were clear outliers due to also failing QC during the 399 library preparation. Counts were converted into log2 counts per million (cpm) values with 0.5 prior 400 counts to avoid taking the logarithm of zero and were then taken forward to the multi-cohort quality 401 control. Illumina HT-12v4 bead array data were pre-processed by background subtraction, quantile 402 normalization and log2-transformation using the limma package in R. 58 Probes were collapsed to 403 HUGO gene identifiers keeping only the highest expressed probe. 404
Data download 405
Previously published whole blood transcriptional array data was downloaded from the Gene 406 investigating blood stage Plasmodium falciparum (bsPf; two cohorts of blood-stage, HIV-negative 408 malaria cohorts; children and adults), 10,16 acute uncomplicated dengue (DENV; four adult South-East 409
Asian cohorts of uncomplicated dengue fever patients), 9, 18, 19 and active pulmonary tuberculosis (PTb; 410 four cohorts of active, pulmonary TB HIV-negative adults from Africa and the UK), 8, 17 all infections 411 which present with undifferentiated fever and are relevant to areas where enteric fever is endemic 412 Table S2 ). Raw data were downloaded from GEO using the getGEO-function 59 and 413 quantile normalization with detection p-values and control probes where available. Probes were 414 collapsed to HUGO gene identifiers keeping only the highest expressed probe. 415
(Supplementary
Data processing and cohort Quality Control 416
Probe sequences on microarrays may not correspond to the most recent release of the human reference 417 genome that was used for the RNAseq alignment. In order to mitigate this potential discrepancy we 418 re-annotated the probes to the Gencode v25/hg38. The new annotations were used as gene names for 419 each probe. To avoid uninformative genes and gender bias only probes common to all datasets, not 420 located on sex chromosomes and with an expression above the lowest tertile of the average expression 421 (12,821 probes) were used and a 'superset' was created by merging the expression data from all 422 studies into one large data matrix. In order to avoid platform or study related artefacts between the 423 data we applied surrogate variable analysis (sva) 60 to remove batch effects based on study ID while 424 preserving the disease condition (i.e. control or individual infection). 425
Diagnostic signature identification 426
For classification analyses, we separated the superset into a discovery cohort and a validation cohort. 427
To ensure heterogeneity and optimal feature identification we restricted the discovery cohort to 428 samples solely generated on Illumina platforms and ensured inclusion of EF samples from Oxford and 429
Nepal. In order to establish a validation cohort we casted a wider net and permitted studies generated 430 on other platforms including Affymetrix due to the limited amount of suitable datasets available in the 431 public domain. In addition, to predict unknown samples by applying the signatures identified in this 432 study, we separated the febrile, culture-negative suspected enteric fever cases, samples at day 7 after 433 challenge of those who stayed well and their respective pre-challenge control samples from the 434 superset into a cohort of samples of unknown aetiology (Unknown Cohort) (Figure 2) . 435
Only the discovery cohort was used for feature selection using Guided Regularized Random Forest 436 (GRRF) 20 as implemented in the R package RRF v1.7 61 with gamma = 0.5 and parameter mtry tuning 437 was performed using the tuneRRF command. Feature selection was repeated on 100 iterations of 438 bootstrapped subsets of about 70% of the data in the discovery cohort. To assess model performance, 439 predictions on the held out 30% of the discovery cohort were performed and balanced accuracies 62 440 were recorded to account for class imbalances. Genes were then ranked by the frequency of positive 441 gene selection by GRRF (based on mean Gini) during the 100 iterations and only genes included in at 442 least 25% of the selection rounds were included in the diagnostic signature and used for prediction of 443 the independent validation cohort as well as the samples belonging to the unknown cohort (Figure 2) . 444
High-throughput qPCR validation 445
We performed TaqMan 
Statistical analysis 453
All data were processed in R version 3.2.4. Comparison of groups in Figure 3d were performed using 454 Student's t-Test and correlations between clinical parameters and expression scores were performed 455 using Pearson correlation and correlation between array and qPCR expression as performed using 456
Spearman correlations (alternative: two-sided). 457
Data deposition: 458
The datasets generated in these studies were deposited at GEO: GSE113867. 459
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